Global Cell Gene Therapy Biomanufacturing Market Outlook , 2030
The Global Cell Gene Therapy Biomanufacturing Market forecasts a growth rate of over 3.7%, fueled by advancements in gene therapies and increased biomanufacturing capabilities.
- Bonafide Trust
- 10-07-2024
- Pages : 85
- Figures : 80
- Tables : 95
- Region : Global
- Category : Lifescience & Healthcare
- Healthcare
The global cell and gene therapy biomanufacturing market is experiencing rapid growth driven by the increasing number of approved therapies and expanding target indications. Cell and gene therapies have the potential to treat chronic and rare diseases that previously had limited treatment options. Over the past decade, more than 25 cell and gene therapies have been approved by the FDA, resulting from years of pioneering research. This growth is expected to continue as the market is currently in a progressing phase.One of the most promising aspects of the cell and gene therapy market is the integration of advanced technologies such as artificial intelligence (AI) and machine learning (ML) into the manufacturing process. These technologies can enhance efficiency, optimize production workflows, and improve quality control, addressing some of the critical challenges faced by manufacturers. For instance, automating the production of lentiviral vectors, which are often a bottleneck in the manufacturing process, can significantly reduce costs and increase output. As the industry continues to adopt these technologies, the potential for scaling up production to meet global demand becomes more feasible.The future of the cell and gene therapy biomanufacturing market also hinges on evolving regulatory frameworks. Regulatory agencies, including the FDA, are adapting their guidelines to facilitate the approval of innovative therapies while ensuring patient safety. Recent draft guidance documents from the FDA address manufacturing changes and product consistency, providing clearer pathways for developers to navigate the complex regulatory landscape. This supportive environment is crucial for fostering innovation and encouraging investment in the sector.
According to the research report " Global Cell Gene Therapy Biomanufacturing Market Outlook, 2030," published by Bonafide Research, Global Cell Gene Therapy Biomanufacturing Market is anticipated to grow at more than 3.7% CAGR from 2024 to 2030. The global cell and gene therapy biomanufacturing market is at a pivotal moment, characterized by rapid advancements and increasing demand for innovative therapies. This market encompasses the production processes involved in creating cell and gene therapies, which are designed to treat a range of diseases, including genetic disorders, cancers, and other chronic conditions. The growth of this sector is driven by several factors, including technological advancements, regulatory support, and an expanding patient population that requires effective treatment options.The gene therapy segment is expected to expand by a significant CAGR during the forecast period. With a large number of products currently in clinical trials, production process improvement has become a major need for the gene therapy manufacturing market. With an increase in investments from players and the clinical success of more products, several gene therapy companies are focusing on manufacturing and commercialization. Evaluating the existing process and its scalability, as well as for deciding on in-house or outsourced manufacturing, are some of the major factors to be considered while designing the manufacturing process for gene therapy products. Some of the key global companies are undertaking various strategic initiatives to boost their presence in the gene therapy manufacturing market. For instance, in September 2020, Pfizer collaborated with Vivet Therapeutics to manufacture Wilson's disease candidate.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleMarket Dynamics
Market Drivers
• Increased Number of Approved Therapies : The growing number of approved cell and gene therapies is a major driver for the biomanufacturing market. As more therapies become available, the demand for consumables, equipment, and software solutions required for manufacturing increases. This trend is expected to continue as the market matures and more therapies are approved in the coming years. Since 2017, the FDA has approved over 30 cell and gene therapies, reflecting the growing confidence in the efficacy of these treatments and their potential to address previously untreatable conditions. The number of clinical trials for gene and cell therapies has also increased dramatically, rising from approximately 1,000 to over 1,600 in recent years, indicating a burgeoning interest from both established pharmaceutical companies and new entrants in the biomanufacturing space.
• Expansion in Target Indications : The expansion of target indications for cell and gene therapies is another significant driver. As these therapies prove effective in treating chronic and rare diseases, the potential patient population increases. This creates a demand for large-scale biomanufacturing to meet the growing needs of the market. The ability of cell and gene therapies to address unmet medical needs in various disease areas is a key factor driving their adoption and the corresponding growth in biomanufacturing. The ability of cell and gene therapies to address unmet medical needs in various disease areas is a key factor driving their adoption and the corresponding growth in biomanufacturing. The number of regenerative medicine therapy product developers has increased from 900 to at least 2,700 globally since 2018, further demonstrating the expanding target indications for these therapies.
Market Challenges
• High Set-Up Cost of Biomanufacturing Facilities : One of the significant challenges facing the silicomanganese market is the price volatility of raw materials, particularly silicon metal and manganese ore. Fluctuations in the prices of these essential inputs can impact production costs and profitability for manufacturers. As the market becomes increasingly competitive, companies must develop strategies to manage these price changes effectively. Additionally, supply chain disruptions can exacerbate these challenges, making it crucial for producers to establish reliable sourcing and inventory management practices to mitigate risks associated with raw material costs.
• Ensuring Product Quality and Consistency: Maintaining product quality and consistency is a critical challenge in cell and gene therapy biomanufacturing. The complex nature of these therapies and the variability in starting materials can make it difficult to ensure consistent product quality. Manufacturers must invest in robust quality control measures and process optimization to overcome this challenge. The manufacturing process often involves manual labor, which is both time-consuming and expensive, making scalability a key issue. Automating and optimizing the manufacturing process is crucial for ensuring consistent product quality and meeting the growing demand for these therapies. Market Trends
Trends :
• Adoption of Closed and Variable Manufacturing Systems: The market is witnessing an increase in the adoption of closed and variable manufacturing systems. These systems are designed to reduce the risk of contamination and improve the efficiency of the production process. Closed systems minimize the exposure of the product to the external environment, while variable systems allow for flexibility in manufacturing different therapies. The adoption of these technologies is a key trend driving the growth of the cell and gene therapy biomanufacturing market. Automated and closed system manufacturing of cellular therapy products can help address current manufacturing obstacles and improve product consistency.
• Increasing Use of Artificial Intelligence (AI) and Machine Learning (ML) : The integration of advanced technologies such as artificial intelligence (AI) and machine learning (ML) into the manufacturing process is another major trend. These technologies can enhance efficiency, optimize production workflows, and improve quality control, addressing some of the critical challenges faced by manufacturers. For example, automating the production of lentiviral vectors, which are often a bottleneck in the manufacturing process, can significantly reduce costs and increase output. The use of AI and ML in biomanufacturing is expected to continue growing as the industry seeks to optimize processes and meet the increasing demand for cell and gene therapies.
End User :
• Life Science Companies: Life science companies are a major end user of cell and gene therapy biomanufacturing services. These companies are actively involved in the research, development, and commercialization of cell and gene therapies. They rely on biomanufacturing services to produce the necessary materials for their clinical trials and commercial products. The increasing number of approved therapies and ongoing clinical trials has amplified the demand for biomanufacturing services, driving life science companies to seek reliable partners for production and quality assurance.
• Contract Manufacturing Organizations (CMOs): Contract manufacturing organizations (CMOs) are another significant end user of cell and gene therapy biomanufacturing services. CMOs provide outsourced manufacturing services to pharmaceutical and biotechnology companies. They offer expertise in process development, scale-up, and production of cell and gene therapies. The growth of the CMO market is driven by the increasing demand for outsourced manufacturing services from cell and gene therapy developers. As life science companies focus on innovation, they are turning to CMOs to leverage their expertise and facilities for the production of therapies.
Segmentation Analysis
Based on the report the product type is segmented into Consumables , Equipment , Software Solutions
Consumables are an essential component of cell and gene therapy biomanufacturing. They include reagents, media, and other materials required for the manufacturing process. The demand for consumables is expected to grow as the number of approved therapies increases and more patients receive treatment. Manufacturers must ensure a reliable supply of high-quality consumables to maintain consistent product quality. Specialized equipment is necessary for the production of cell and gene therapies. This includes bioreactors, centrifuges, and purification systems. The market for cell and gene therapy biomanufacturing equipment is expected to grow as manufacturers invest in new facilities and upgrade existing ones. Manufacturers must choose equipment that meets their specific needs and complies with regulatory requirements. Software solutions play a crucial role in cell and gene therapy biomanufacturing. They are used for process control, data management, and regulatory compliance. The market for biomanufacturing software solutions is expected to grow as manufacturers seek to optimize their processes and ensure product quality. Software solutions can help streamline manufacturing workflows, improve data integrity, and facilitate regulatory reporting. The use of AI and ML in software solutions is a key trend, as these technologies can enhance efficiency and optimize production processes.
Based on the report the application is segmented into Life Science Companies, Contract Research Organizations , Contract Manufacturing Organizations , Cell Banks
Life science companies are the primary end users of cell and gene therapy biomanufacturing services. These companies are responsible for the research, development, and commercialization of these therapies. They rely on biomanufacturing services to produce the necessary materials for their clinical trials and commercial products. The growth of the life science company segment is driven by the increasing number of cell and gene therapy candidates in the pipeline and the expanding target indications. Contract research organizations (CROs) are another significant end user of cell and gene therapy biomanufacturing services. CROs provide outsourced research and development services to pharmaceutical and biotechnology companies. They offer expertise in preclinical and clinical testing of cell and gene therapies. Contract manufacturing organizations (CMOs) are a crucial end user of cell and gene therapy biomanufacturing services. CMOs provide outsourced manufacturing services to pharmaceutical and biotechnology companies. Cell banks are another vital component of the cell and gene therapy biomanufacturing market. These facilities are responsible for the storage and management of cell lines used in the production of therapies. Cell banks ensure the availability of high-quality, standardized cell materials that are critical for consistent manufacturing processes.
Regional Analysis
North America is a leading region in the global cell and gene therapy biomanufacturing market. The region is home to a large number of cell and gene therapy developers and has a well-established biomanufacturing infrastructure.
The United States, in particular, is a major contributor to the growth of the North American market due to its supportive regulatory environment and significant investments in the field. Europe is another key region in the global cell and gene therapy biomanufacturing market. The region has a strong presence of cell and gene therapy developers and is actively investing in biomanufacturing facilities. The Asia-Pacific region is expected to be a high-growth market for cell and gene therapy biomanufacturing. Countries like China, Japan, and South Korea are investing heavily in the development of cell and gene therapies and are building biomanufacturing capabilities. The region's large patient population, growing healthcare expenditure, and increasing adoption of advanced therapies are driving the growth of the Asia-Pacific market.
Key Development
• January 2020: Thermo Fisher Scientific Inc. announced the acquisition of Brammer Bio, a leading viral vector CDMO for gene therapies and vaccines.
• March 2021: Lonza Group AG opened a new cell and gene therapy manufacturing facility in Stein, Switzerland.
• June 2022: Merck KGaA announced the expansion of its viral vector manufacturing facility in Carlsbad, California.
• September 2023: Sartorius AG acquired Novasep's chromatography and membrane adsorber business to strengthen its position in the cell and gene therapy biomanufacturing market.
• November 2023: Bio-Rad Laboratories, Inc. launched a new line of consumables for cell and gene therapy biomanufacturing.
Table of Contents
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Cell Gene Therapy Biomanufacturing Market Size 2019-2030
- 2.1.2 Cell Gene Therapy Biomanufacturing Market Size CAGR by Region (2019 VS 2023 VS 2030)
- 2.1.3 World Current & Future Analysis for Cell Gene Therapy Biomanufacturing by Country/Region, 2019, 2023 & 2030
- 2.2 Cell Gene Therapy Biomanufacturing Segment by Type
- 2.2.1 Consumables
- 2.2.2 Equipment
- 2.2.3 Software Solutions
- 2.3 Cell Gene Therapy Biomanufacturing Market Size by Type
- 2.3.1 Cell Gene Therapy Biomanufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030)
- 2.3.2 Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
- 2.4 Cell Gene Therapy Biomanufacturing Segment by Application
- 2.4.1 Life Science Companies
- 2.4.2 Contract Research Organizations
- 2.4.3 Contract Manufacturing Organizations
- 2.4.4 Cell Banks
- 2.5 Cell Gene Therapy Biomanufacturing Market Size by Application
- 2.5.1 Cell Gene Therapy Biomanufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030)
- 2.5.2 Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
- 3 Cell Gene Therapy Biomanufacturing Market Size by Player
- 3.1 Cell Gene Therapy Biomanufacturing Market Size Market Share by Player
- 3.1.1 Global Cell Gene Therapy Biomanufacturing Revenue by Player (2019-2024)
- 3.1.2 Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Player (2019-2024)
- 3.2 Global Cell Gene Therapy Biomanufacturing Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
- 4 Cell Gene Therapy Biomanufacturing by Region
- 4.1 Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024)
- 4.2 Global Cell Gene Therapy Biomanufacturing Annual Revenue by Country/Region (2019-2024)
- 4.3 Americas Cell Gene Therapy Biomanufacturing Market Size Growth (2019-2024)
- 4.4 APAC Cell Gene Therapy Biomanufacturing Market Size Growth (2019-2024)
- 4.5 Europe Cell Gene Therapy Biomanufacturing Market Size Growth (2019-2024)
- 4.6 Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size Growth (2019-2024)
- 5 Americas
- 5.1 Americas Cell Gene Therapy Biomanufacturing Market Size by Country (2019-2024)
- 5.2 Americas Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024)
- 5.3 Americas Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024)
- 6.2 APAC Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024)
- 6.3 APAC Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024)
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 7 Europe
- 7.1 Europe Cell Gene Therapy Biomanufacturing Market Size by Country (2019-2024)
- 7.2 Europe Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024)
- 7.3 Europe Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Cell Gene Therapy Biomanufacturing by Region (2019-2024)
- 8.2 Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024)
- 8.3 Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Global Cell Gene Therapy Biomanufacturing Market Forecast
- 10.1 Global Cell Gene Therapy Biomanufacturing Forecast by Region (2025-2030)
- 10.1.1 Global Cell Gene Therapy Biomanufacturing Forecast by Region (2025-2030)
- 10.1.2 Americas Cell Gene Therapy Biomanufacturing Forecast
- 10.1.3 APAC Cell Gene Therapy Biomanufacturing Forecast
- 10.1.4 Europe Cell Gene Therapy Biomanufacturing Forecast
- 10.1.5 Middle East & Africa Cell Gene Therapy Biomanufacturing Forecast
- 10.2 Americas Cell Gene Therapy Biomanufacturing Forecast by Country (2025-2030)
- 10.2.1 United States Market Cell Gene Therapy Biomanufacturing Forecast
- 10.2.2 Canada Market Cell Gene Therapy Biomanufacturing Forecast
- 10.2.3 Mexico Market Cell Gene Therapy Biomanufacturing Forecast
- 10.2.4 Brazil Market Cell Gene Therapy Biomanufacturing Forecast
- 10.3 APAC Cell Gene Therapy Biomanufacturing Forecast by Region (2025-2030)
- 10.3.1 China Cell Gene Therapy Biomanufacturing Market Forecast
- 10.3.2 Japan Market Cell Gene Therapy Biomanufacturing Forecast
- 10.3.3 Korea Market Cell Gene Therapy Biomanufacturing Forecast
- 10.3.4 Southeast Asia Market Cell Gene Therapy Biomanufacturing Forecast
- 10.3.5 India Market Cell Gene Therapy Biomanufacturing Forecast
- 10.3.6 Australia Market Cell Gene Therapy Biomanufacturing Forecast
- 10.4 Europe Cell Gene Therapy Biomanufacturing Forecast by Country (2025-2030)
- 10.4.1 Germany Market Cell Gene Therapy Biomanufacturing Forecast
- 10.4.2 France Market Cell Gene Therapy Biomanufacturing Forecast
- 10.4.3 UK Market Cell Gene Therapy Biomanufacturing Forecast
- 10.4.4 Italy Market Cell Gene Therapy Biomanufacturing Forecast
- 10.4.5 Russia Market Cell Gene Therapy Biomanufacturing Forecast
- 10.5 Middle East & Africa Cell Gene Therapy Biomanufacturing Forecast by Region (2025-2030)
- 10.5.1 Egypt Market Cell Gene Therapy Biomanufacturing Forecast
- 10.5.2 South Africa Market Cell Gene Therapy Biomanufacturing Forecast
- 10.5.3 Israel Market Cell Gene Therapy Biomanufacturing Forecast
- 10.5.4 Turkey Market Cell Gene Therapy Biomanufacturing Forecast
- 10.6 Global Cell Gene Therapy Biomanufacturing Forecast by Type (2025-2030)
- 10.7 Global Cell Gene Therapy Biomanufacturing Forecast by Application (2025-2030)
- 10.7.1 GCC Countries Market Cell Gene Therapy Biomanufacturing Forecast
- 11 Key Players Analysis
- 11.1 Lonza Group
- 11.1.1 Lonza Group Company Information
- 11.1.2 Lonza Group Cell Gene Therapy Biomanufacturing Product Offered
- 11.1.3 Lonza Group Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.1.4 Lonza Group Main Business Overview
- 11.1.5 Lonza Group Latest Developments
- 11.2 Thermo Fisher Scientific Inc.
- 11.2.1 Thermo Fisher Scientific Inc. Company Information
- 11.2.2 Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Product Offered
- 11.2.3 Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.2.4 Thermo Fisher Scientific Inc. Main Business Overview
- 11.2.5 Thermo Fisher Scientific Inc. Latest Developments
- 11.3 Merck KGaA
- 11.3.1 Merck KGaA Company Information
- 11.3.2 Merck KGaA Cell Gene Therapy Biomanufacturing Product Offered
- 11.3.3 Merck KGaA Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.3.4 Merck KGaA Main Business Overview
- 11.3.5 Merck KGaA Latest Developments
- 11.4 WuXi AppTec
- 11.4.1 WuXi AppTec Company Information
- 11.4.2 WuXi AppTec Cell Gene Therapy Biomanufacturing Product Offered
- 11.4.3 WuXi AppTec Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.4.4 WuXi AppTec Main Business Overview
- 11.4.5 WuXi AppTec Latest Developments
- 11.5 Catalent, Inc.
- 11.5.1 Catalent, Inc. Company Information
- 11.5.2 Catalent, Inc. Cell Gene Therapy Biomanufacturing Product Offered
- 11.5.3 Catalent, Inc. Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.5.4 Catalent, Inc. Main Business Overview
- 11.5.5 Catalent, Inc. Latest Developments
- 11.6 Samsung Biologics
- 11.6.1 Samsung Biologics Company Information
- 11.6.2 Samsung Biologics Cell Gene Therapy Biomanufacturing Product Offered
- 11.6.3 Samsung Biologics Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.6.4 Samsung Biologics Main Business Overview
- 11.6.5 Samsung Biologics Latest Developments
- 11.7 FUJIFILM Diosynth Biotechnologies
- 11.7.1 FUJIFILM Diosynth Biotechnologies Company Information
- 11.7.2 FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Product Offered
- 11.7.3 FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.7.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
- 11.7.5 FUJIFILM Diosynth Biotechnologies Latest Developments
- 11.8 Charles River Laboratories
- 11.8.1 Charles River Laboratories Company Information
- 11.8.2 Charles River Laboratories Cell Gene Therapy Biomanufacturing Product Offered
- 11.8.3 Charles River Laboratories Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.8.4 Charles River Laboratories Main Business Overview
- 11.8.5 Charles River Laboratories Latest Developments
- 11.9 Cytiva
- 11.9.1 Cytiva Company Information
- 11.9.2 Cytiva Cell Gene Therapy Biomanufacturing Product Offered
- 11.9.3 Cytiva Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.9.4 Cytiva Main Business Overview
- 11.9.5 Cytiva Latest Developments
- 11.10 Novasep
- 11.10.1 Novasep Company Information
- 11.10.2 Novasep Cell Gene Therapy Biomanufacturing Product Offered
- 11.10.3 Novasep Cell Gene Therapy Biomanufacturing Revenue, Gross Margin and Market Share (2019-2024)
- 11.10.4 Novasep Main Business Overview
- 11.10.5 Novasep Latest Developments
- 12 Research Findings and Conclusion
List of Tables
Table 1. Cell Gene Therapy Biomanufacturing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Cell Gene Therapy Biomanufacturing Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Consumables
Table 4. Major Players of Equipment
Table 5. Major Players of Software Solutions
Table 6. Cell Gene Therapy Biomanufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Table 9. Cell Gene Therapy Biomanufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Table 12. Global Cell Gene Therapy Biomanufacturing Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Player (2019-2024)
Table 14. Cell Gene Therapy Biomanufacturing Key Players Head office and Products Offered
Table 15. Cell Gene Therapy Biomanufacturing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Region (2019-2024)
Table 20. Global Cell Gene Therapy Biomanufacturing Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Cell Gene Therapy Biomanufacturing Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Cell Gene Therapy Biomanufacturing Market Size Market Share by Country (2019-2024)
Table 24. Americas Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Table 26. Americas Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Table 28. APAC Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Cell Gene Therapy Biomanufacturing Market Size Market Share by Region (2019-2024)
Table 30. APAC Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Cell Gene Therapy Biomanufacturing Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Cell Gene Therapy Biomanufacturing Market Size Market Share by Country (2019-2024)
Table 34. Europe Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Cell Gene Therapy Biomanufacturing
Table 40. Key Market Challenges & Risks of Cell Gene Therapy Biomanufacturing
Table 41. Key Industry Trends of Cell Gene Therapy Biomanufacturing
Table 42. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Cell Gene Therapy Biomanufacturing Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Lonza Group Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 47. Lonza Group Cell Gene Therapy Biomanufacturing Product Offered
Table 48. Lonza Group Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Lonza Group Main Business
Table 50. Lonza Group Latest Developments
Table 51. Thermo Fisher Scientific Inc. Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 52. Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Product Offered
Table 53. Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Thermo Fisher Scientific Inc. Main Business
Table 55. Thermo Fisher Scientific Inc. Latest Developments
Table 56. Merck KGaA Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 57. Merck KGaA Cell Gene Therapy Biomanufacturing Product Offered
Table 58. Merck KGaA Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Merck KGaA Main Business
Table 60. Merck KGaA Latest Developments
Table 61. WuXi AppTec Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 62. WuXi AppTec Cell Gene Therapy Biomanufacturing Product Offered
Table 63. WuXi AppTec Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. WuXi AppTec Main Business
Table 65. WuXi AppTec Latest Developments
Table 66. Catalent, Inc. Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 67. Catalent, Inc. Cell Gene Therapy Biomanufacturing Product Offered
Table 68. Catalent, Inc. Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Catalent, Inc. Main Business
Table 70. Catalent, Inc. Latest Developments
Table 71. Samsung Biologics Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 72. Samsung Biologics Cell Gene Therapy Biomanufacturing Product Offered
Table 73. Samsung Biologics Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Samsung Biologics Main Business
Table 75. Samsung Biologics Latest Developments
Table 76. FUJIFILM Diosynth Biotechnologies Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 77. FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Product Offered
Table 78. FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. FUJIFILM Diosynth Biotechnologies Main Business
Table 80. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 81. Charles River Laboratories Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 82. Charles River Laboratories Cell Gene Therapy Biomanufacturing Product Offered
Table 83. Charles River Laboratories Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Charles River Laboratories Main Business
Table 85. Charles River Laboratories Latest Developments
Table 86. Cytiva Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 87. Cytiva Cell Gene Therapy Biomanufacturing Product Offered
Table 88. Cytiva Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Cytiva Main Business
Table 90. Cytiva Latest Developments
Table 91. Novasep Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 92. Novasep Cell Gene Therapy Biomanufacturing Product Offered
Table 93. Novasep Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Novasep Main Business
Table 95. Novasep Latest Developments
Table 1. Cell Gene Therapy Biomanufacturing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Cell Gene Therapy Biomanufacturing Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Consumables
Table 4. Major Players of Equipment
Table 5. Major Players of Software Solutions
Table 6. Cell Gene Therapy Biomanufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Table 9. Cell Gene Therapy Biomanufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Table 12. Global Cell Gene Therapy Biomanufacturing Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Player (2019-2024)
Table 14. Cell Gene Therapy Biomanufacturing Key Players Head office and Products Offered
Table 15. Cell Gene Therapy Biomanufacturing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Region (2019-2024)
Table 20. Global Cell Gene Therapy Biomanufacturing Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Cell Gene Therapy Biomanufacturing Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Cell Gene Therapy Biomanufacturing Market Size Market Share by Country (2019-2024)
Table 24. Americas Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Table 26. Americas Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Table 28. APAC Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Cell Gene Therapy Biomanufacturing Market Size Market Share by Region (2019-2024)
Table 30. APAC Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Cell Gene Therapy Biomanufacturing Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Cell Gene Therapy Biomanufacturing Market Size Market Share by Country (2019-2024)
Table 34. Europe Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Cell Gene Therapy Biomanufacturing
Table 40. Key Market Challenges & Risks of Cell Gene Therapy Biomanufacturing
Table 41. Key Industry Trends of Cell Gene Therapy Biomanufacturing
Table 42. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Cell Gene Therapy Biomanufacturing Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Cell Gene Therapy Biomanufacturing Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Lonza Group Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 47. Lonza Group Cell Gene Therapy Biomanufacturing Product Offered
Table 48. Lonza Group Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Lonza Group Main Business
Table 50. Lonza Group Latest Developments
Table 51. Thermo Fisher Scientific Inc. Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 52. Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Product Offered
Table 53. Thermo Fisher Scientific Inc. Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Thermo Fisher Scientific Inc. Main Business
Table 55. Thermo Fisher Scientific Inc. Latest Developments
Table 56. Merck KGaA Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 57. Merck KGaA Cell Gene Therapy Biomanufacturing Product Offered
Table 58. Merck KGaA Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Merck KGaA Main Business
Table 60. Merck KGaA Latest Developments
Table 61. WuXi AppTec Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 62. WuXi AppTec Cell Gene Therapy Biomanufacturing Product Offered
Table 63. WuXi AppTec Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. WuXi AppTec Main Business
Table 65. WuXi AppTec Latest Developments
Table 66. Catalent, Inc. Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 67. Catalent, Inc. Cell Gene Therapy Biomanufacturing Product Offered
Table 68. Catalent, Inc. Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Catalent, Inc. Main Business
Table 70. Catalent, Inc. Latest Developments
Table 71. Samsung Biologics Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 72. Samsung Biologics Cell Gene Therapy Biomanufacturing Product Offered
Table 73. Samsung Biologics Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Samsung Biologics Main Business
Table 75. Samsung Biologics Latest Developments
Table 76. FUJIFILM Diosynth Biotechnologies Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 77. FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Product Offered
Table 78. FUJIFILM Diosynth Biotechnologies Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. FUJIFILM Diosynth Biotechnologies Main Business
Table 80. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 81. Charles River Laboratories Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 82. Charles River Laboratories Cell Gene Therapy Biomanufacturing Product Offered
Table 83. Charles River Laboratories Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Charles River Laboratories Main Business
Table 85. Charles River Laboratories Latest Developments
Table 86. Cytiva Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 87. Cytiva Cell Gene Therapy Biomanufacturing Product Offered
Table 88. Cytiva Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Cytiva Main Business
Table 90. Cytiva Latest Developments
Table 91. Novasep Details, Company Type, Cell Gene Therapy Biomanufacturing Area Served and Its Competitors
Table 92. Novasep Cell Gene Therapy Biomanufacturing Product Offered
Table 93. Novasep Cell Gene Therapy Biomanufacturing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Novasep Main Business
Table 95. Novasep Latest Developments
List of Figures
Figure 1. Cell Gene Therapy Biomanufacturing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell Gene Therapy Biomanufacturing Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Cell Gene Therapy Biomanufacturing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cell Gene Therapy Biomanufacturing Sales Market Share by Country/Region (2023)
Figure 8. Cell Gene Therapy Biomanufacturing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Type in 2023
Figure 10. Cell Gene Therapy Biomanufacturing in Life Science Companies
Figure 11. Global Cell Gene Therapy Biomanufacturing Market: Life Science Companies (2019-2024) & ($ millions)
Figure 12. Cell Gene Therapy Biomanufacturing in Contract Research Organizations
Figure 13. Global Cell Gene Therapy Biomanufacturing Market: Contract Research Organizations (2019-2024) & ($ millions)
Figure 14. Cell Gene Therapy Biomanufacturing in Contract Manufacturing Organizations
Figure 15. Global Cell Gene Therapy Biomanufacturing Market: Contract Manufacturing Organizations (2019-2024) & ($ millions)
Figure 16. Cell Gene Therapy Biomanufacturing in Cell Banks
Figure 17. Global Cell Gene Therapy Biomanufacturing Market: Cell Banks (2019-2024) & ($ millions)
Figure 18. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Application in 2023
Figure 19. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Player in 2023
Figure 20. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Region (2019-2024)
Figure 21. Americas Cell Gene Therapy Biomanufacturing Market Size 2019-2024 ($ millions)
Figure 22. APAC Cell Gene Therapy Biomanufacturing Market Size 2019-2024 ($ millions)
Figure 23. Europe Cell Gene Therapy Biomanufacturing Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size 2019-2024 ($ millions)
Figure 25. Americas Cell Gene Therapy Biomanufacturing Value Market Share by Country in 2023
Figure 26. United States Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC Cell Gene Therapy Biomanufacturing Market Size Market Share by Region in 2023
Figure 31. APAC Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Figure 32. APAC Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Figure 33. China Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 37. India Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe Cell Gene Therapy Biomanufacturing Market Size Market Share by Country in 2023
Figure 40. Europe Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Figure 41. Europe Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Figure 42. Germany Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 43. France Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 44. UK Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 56. APAC Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 57. Europe Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 59. United States Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 60. Canada Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 61. Mexico Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 62. Brazil Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 63. China Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 64. Japan Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 65. Korea Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 67. India Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 68. Australia Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 69. Germany Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 70. France Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 71. UK Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 72. Italy Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 73. Russia Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 74. Egypt Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 75. South Africa Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 76. Israel Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 77. Turkey Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 79. Global Cell Gene Therapy Biomanufacturing Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global Cell Gene Therapy Biomanufacturing Market Size Market Share Forecast by Application (2025-2030)
"
Figure 1. Cell Gene Therapy Biomanufacturing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell Gene Therapy Biomanufacturing Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Cell Gene Therapy Biomanufacturing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Cell Gene Therapy Biomanufacturing Sales Market Share by Country/Region (2023)
Figure 8. Cell Gene Therapy Biomanufacturing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Type in 2023
Figure 10. Cell Gene Therapy Biomanufacturing in Life Science Companies
Figure 11. Global Cell Gene Therapy Biomanufacturing Market: Life Science Companies (2019-2024) & ($ millions)
Figure 12. Cell Gene Therapy Biomanufacturing in Contract Research Organizations
Figure 13. Global Cell Gene Therapy Biomanufacturing Market: Contract Research Organizations (2019-2024) & ($ millions)
Figure 14. Cell Gene Therapy Biomanufacturing in Contract Manufacturing Organizations
Figure 15. Global Cell Gene Therapy Biomanufacturing Market: Contract Manufacturing Organizations (2019-2024) & ($ millions)
Figure 16. Cell Gene Therapy Biomanufacturing in Cell Banks
Figure 17. Global Cell Gene Therapy Biomanufacturing Market: Cell Banks (2019-2024) & ($ millions)
Figure 18. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Application in 2023
Figure 19. Global Cell Gene Therapy Biomanufacturing Revenue Market Share by Player in 2023
Figure 20. Global Cell Gene Therapy Biomanufacturing Market Size Market Share by Region (2019-2024)
Figure 21. Americas Cell Gene Therapy Biomanufacturing Market Size 2019-2024 ($ millions)
Figure 22. APAC Cell Gene Therapy Biomanufacturing Market Size 2019-2024 ($ millions)
Figure 23. Europe Cell Gene Therapy Biomanufacturing Market Size 2019-2024 ($ millions)
Figure 24. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size 2019-2024 ($ millions)
Figure 25. Americas Cell Gene Therapy Biomanufacturing Value Market Share by Country in 2023
Figure 26. United States Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 27. Canada Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 28. Mexico Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 29. Brazil Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 30. APAC Cell Gene Therapy Biomanufacturing Market Size Market Share by Region in 2023
Figure 31. APAC Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Figure 32. APAC Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Figure 33. China Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 34. Japan Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 35. South Korea Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 36. Southeast Asia Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 37. India Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 38. Australia Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 39. Europe Cell Gene Therapy Biomanufacturing Market Size Market Share by Country in 2023
Figure 40. Europe Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Figure 41. Europe Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Figure 42. Germany Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 43. France Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 44. UK Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 45. Italy Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 46. Russia Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 47. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 51. South Africa Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 52. Israel Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 53. Turkey Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 54. GCC Countries Cell Gene Therapy Biomanufacturing Market Size Growth 2019-2024 ($ millions)
Figure 55. Americas Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 56. APAC Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 57. Europe Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 58. Middle East & Africa Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 59. United States Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 60. Canada Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 61. Mexico Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 62. Brazil Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 63. China Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 64. Japan Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 65. Korea Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 66. Southeast Asia Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 67. India Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 68. Australia Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 69. Germany Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 70. France Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 71. UK Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 72. Italy Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 73. Russia Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 74. Egypt Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 75. South Africa Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 76. Israel Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 77. Turkey Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 78. GCC Countries Cell Gene Therapy Biomanufacturing Market Size 2025-2030 ($ millions)
Figure 79. Global Cell Gene Therapy Biomanufacturing Market Size Market Share Forecast by Type (2025-2030)
Figure 80. Global Cell Gene Therapy Biomanufacturing Market Size Market Share Forecast by Application (2025-2030)
"
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (09 May, 2026)
- Notify To Team (09 May, 2026)
- Report updation (10 May, 2026)
- Report Quality Check (10 May, 2026)
- Report Dispatch (11 May, 2026)
- Hard Copy
Recently Viewed Products
Global Cell Gene Therapy Biomanufacturing Market Outlook , 2030
We are friendly and approachable, give us a call.